
Overview
Omar Kayaleh, MD, serves as the medical oncology team leader for the Gastrointestinal Cancers Specialty Section and as a member of the Breast Cancer, Genitourinary Cancers, Hematology, Lymphoma/Myeloma and Thoracic/Head and Neck Cancers Specialty Sections at Orlando Health Cancer Institute. He also served as chairman of the Department of Internal Medicine as well as chief of the Hematology/ Oncology Specialty Section at Orlando Health Cancer Institute.Dr. Kayaleh received his medical degree from the University of Florida, completed a residency in internal medicine at Franklin Square Hospital in Baltimore and fulfilled a fellowship at the Medical University of South Carolina.Dr. Kayaleh is board-certified in internal medicine and in the specialties of medical oncology and hematology. He has held many offices and memberships on numerous medical staff committees, including Pharmacy and Therapeutics.He is a member of the Orange County Medical Society, Florida Medical Association, American Medical Association, American Society of Hematology, and the American Society of Clinical Oncology.
Dr. Kayaleh is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Pancreatic Cancer, Colorectal Cancer, and Lynch Syndrome.
Dr. Kayaleh is board certified in American Board Of Internal Med. - Medical Oncology and American Board Of Internal Medicine - Hematology. He is actively involved in clinical research, co-authoring 7 peer reviewed articles and participating in 5 clinical trials.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- EPO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- EPO
- HMO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1400 S. Orange Ave., Orlando, FL 32806
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
Orlando Health Cancer Institute - Downtown Orlando
Jennifer Tseng, MD, hematologist/medical oncologist, is the Thoracic/Head and Neck Specialty Section leader for Medical Oncology and the associate director of Clinical Research for Medical Oncology at Orlando Health Cancer Institute.Dr. Tseng received her medical degree from Duke University School of Medicine. She completed her residency and served as assistant chief resident in internal medicine at Duke University Medical Center. She completed a fellowship in medical oncology and hematology at The University of Texas MD Anderson Cancer Center in Houston. She is board-certified in internal medicine and medical oncology and board-eligible in hematology. Dr. Tseng has received several honors and awards, including the C.D. Howe Award for clinical excellence in medical oncology and a Clinical Research Award from MD Anderson, the American Medical Women's Award, Hewlett Packard Award, the Alpha Omega Alpha Research Symposium Award from Duke University and a Beneficial-Hodgson scholarship from The Johns Hopkins University. She was also awarded Attending of the Year from the Internal Medicine Residency Program from Orlando Regional Medical Center and received the Exemplary Physician Colleague Award from Orlando Health in 2009.In addition to her clinical studies, Dr. Tseng has published research on various topics including molecular alterations in lung cancer and novel agents in the treatment of head and neck cancer. She has recently presented at the Annual Thoracic Oncology Symposium of the Puerto Rican Society of Hematology Oncology and spoke on neoadjuvant and adjuvant treatment strategies in lung cancer. Dr. Tseng is highly rated in 29 conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Lung Adenocarcinoma. Dr. Tseng is board certified in American Board Of Internal Med. - Medical Oncology and American Board Of Internal Medicine.
Orlando Health Cancer Institute - Downtown Orlando
Dr. Tirrell Johnson is a board-certified medical oncologist at the Orlando Health Cancer Institute. His specialties include: Head and neck cancers Thoracic cancers Melanoma Sarcoma He is a member of the team pioneering a breakthrough protocol using tumor-infiltrating lymphocytes to address aggressive, late-stage melanoma. Dr. Johnson's Training Dr. Johnson earned a bachelor's degree in chemical engineering from Florida A&M University in Tallahassee, graduating magna cum laude, and received his medical degree from the University of Florida in Gainesville. He completed an internal medicine residency at Orlando Health Orlando Regional Medical Center and a fellowship in hematology and oncology at Brown University Medical School's teaching hospitals in Providence, Rhode Island. About Dr. Johnson Dr. Johnson is board certified in internal medicine and medical oncology by the American Board of Internal Medicine. His professional memberships include the American College of Physicians, American Society of Clinical Oncology and American Society of Hematology. Dr. Johnson received an Orlando Health award for outstanding multidisciplinary involvement with staff. He has served as the primary investigator for clinical trials studying several forms of chemotherapy for advanced head and neck cancers and thoracic malignancies. Dr. Johnson is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma. Dr. Johnson is board certified in American Board Of Internal Med. - Medical Oncology and American Board Of Internal Medicine.
Florida Cancer Specialists & Research Institute, LLC
Sonalee Shroff is a Hematologist and an Oncologist practicing medicine in Winter Park, Florida. Dr. Shroff is highly rated in 29 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Angiosarcoma, and Inflammatory Breast Cancer. Dr. Shroff is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine - Hematology.
Frequently Asked Questions about Dr. Omar R. Kayaleh
How do I make an appointment with Dr. Omar R. Kayaleh?
You can book an appointment with Dr. Omar R. Kayaleh by calling their office at 321-841-1869. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Omar R. Kayaleh a top-rated expert for Familial Colorectal Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Omar R. Kayaleh is classified as an Distinguished expert for Familial Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Omar R. Kayaleh specialize in?
While Dr. Omar R. Kayaleh is a Hematology, they have specific expertise in Familial Colorectal Cancer, Pancreatic Cancer, and Colorectal Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Omar R. Kayaleh participate in research or clinical trials?
Yes. Dr. Omar R. Kayaleh has published 7 articles and abstracts on conditions like Familial Colorectal Cancer. You can view a list of Dr. Omar R. Kayaleh's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Omar R. Kayaleh accept my insurance?
Dr. Omar R. Kayaleh accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 321-841-1869 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic Lymphocytic Leukemia (CLL)Dr. Kayaleh isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Colorectal CancerDr. Kayaleh isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Kayaleh isDistinguished. Learn about Familial Colorectal Cancer.
- Familial Pancreatic CancerDr. Kayaleh isDistinguished. Learn about Familial Pancreatic Cancer.
- Gastroesophageal Junction CancerDr. Kayaleh isDistinguished. Learn about Gastroesophageal Junction Cancer.
- Lynch SyndromeDr. Kayaleh isDistinguished. Learn about Lynch Syndrome.
- Advanced
- Anal CancerDr. Kayaleh isAdvanced. Learn about Anal Cancer.
- Appendix CancerDr. Kayaleh isAdvanced. Learn about Appendix Cancer.
- Carcinoid SyndromeDr. Kayaleh isAdvanced. Learn about Carcinoid Syndrome.
- Cholangiocarcinoma (Bile Duct Cancer)
- Fibrolamellar CarcinomaDr. Kayaleh isAdvanced. Learn about Fibrolamellar Carcinoma.
- Gallbladder AdenocarcinomaDr. Kayaleh isAdvanced. Learn about Gallbladder Adenocarcinoma.
- Experienced
- Acinic Cell Carcinoma of Salivary GlandsDr. Kayaleh isExperienced. Learn about Acinic Cell Carcinoma of Salivary Glands.
- Acquired HemophiliaDr. Kayaleh isExperienced. Learn about Acquired Hemophilia.
- Adult Soft Tissue SarcomaDr. Kayaleh isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Kayaleh isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Kayaleh isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Alveolar Soft Part SarcomaDr. Kayaleh isExperienced. Learn about Alveolar Soft Part Sarcoma.

